Cargando…

Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease–Associated Interstitial Lung Disease

OBJECTIVE: Interstitial lung disease (ILD) is a major cause of morbidity and mortality in connective tissue diseases (CTDs). We aimed to assess the effect of rituximab ± mycophenolate mofetil (MMF) compared with MMF on pulmonary function and prednisone dosage in patients with CTD‐related ILD (CTD‐IL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Lisa, Chung, Melody P., Gagne, Laurence, Guo, Haiwei H., Guenther, Zachary, Li, Shufeng, Jacobs, Susan, Morisset, Julie, Mooney, Joshua J., Raj, Rishi, Chung, Lorinda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811692/ https://www.ncbi.nlm.nih.gov/pubmed/33274857 http://dx.doi.org/10.1002/acr2.11210

Ejemplares similares

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases
por: Lamberts, Aniek, et al.
Publicado: (2018)

Recalcitrant Esophageal Stricture Secondary to Mycophenolate Mofetil
por: Kim, Joyce J., et al.
Publicado: (2020)

Recalcitrant lymphocytoma cutis successfully treated with mycophenolate mofetil
por: Mahmood, Farhan, et al.
Publicado: (2021)

Severe recalcitrant otic lichen planus treated with mycophenolate mofetil
por: Guo, Lisa N., et al.
Publicado: (2020)

Recalcitrant urticaria controlled with a combination of mycophenolate mofetil and sulfasalazine
por: Ashbaugh, Alyssa G., et al.
Publicado: (2021)

Recalcitrant vulvar pyoderma gangrenosum successfully treated with mycophenolate mofetil
por: Young, Kelly Z., et al.
Publicado: (2022)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

Low dose of mycophenolate mofetil is enough in desensitized kidney transplantation using rituximab
por: Baek, Chung Hee, et al.
Publicado: (2015)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022)

Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate
por: Hayashi, Masachika, et al.
Publicado: (2017)

Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
por: Vacchi, Caterina, et al.
Publicado: (2021)

Rituximab for the treatment of acute exacerbation of interstitial lung disease associated with connective tissue disease
por: León Román, Francisco, et al.
Publicado: (2023)

Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil
por: Lin, Mike, et al.
Publicado: (2020)

A Recalcitrant Case of Senear-Usher Syndrome Treated With Rituximab
por: de Vries, Jonathan M, et al.
Publicado: (2023)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Rituximab-associated interstitial lung disease in fibrillary glomerulonephritis
por: Sainz-Prestel, Valeria, et al.
Publicado: (2013)

Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis
por: Wang, Pengfei, et al.
Publicado: (2023)

Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
por: Baqir, Misbah, et al.
Publicado: (2017)

Hydroxychloroquine/mycophenolate mofetil/rituximab: Human coronavirus infection: case report
Publicado: (2022)

Rituximab-induced interstitial lung disease: five case reports
por: Naqibullah, Matiuallah, et al.
Publicado: (2015)

A rare case of rituximab induced interstitial lung disease
por: Sahu, Kamal Kant, et al.
Publicado: (2016)

Rituximab treatment in patients with systemic sclerosis and interstitial lung disease
por: Mohammed, Abdel Gaffar A., et al.
Publicado: (2017)

Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review
por: Cassone, Giulia, et al.
Publicado: (2021)

Rituximab for the treatment of connective tissue disease–associated interstitial lung disease: A systematic review and meta-analysis
por: Xu, Linrui, et al.
Publicado: (2022)

A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment
por: Calderazzo, Massimo, et al.
Publicado: (2015)

Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
por: Yang, Yang, et al.
Publicado: (2021)

Immune globulin/mycophenolate mofetil/rituximab: Breakthrough COVID-19: 2 case reports
Publicado: (2022)

Mycophenolate-mofetil/prednisolone/rituximab: Treatment-related osteopenia and candidiasis: 7 case reports
Publicado: (2022)

A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids
por: Sieradzka, Agnieszka Ewa, et al.
Publicado: (2022)

Mycophenolate therapy in interstitial pneumonia with autoimmune features: a cohort study
por: McCoy, Sara S, et al.
Publicado: (2018)

Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
por: Scirocco, Chiara, et al.
Publicado: (2020)

Rituximab-Induced Interstitial Lung Disease: A Stitch in Time Saved Nine
por: Tej, Sai, et al.
Publicado: (2022)

Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis
por: Tzouvelekis, Argyris, et al.
Publicado: (2012)

Mycophenolate Mofetil Improves Exercise Tolerance in Systemic Sclerosis Patients with Interstitial Lung Disease: A Pilot Study
por: Vaiarello, Valentina, et al.
Publicado: (2020)

Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use
por: Kreuter, Michael, et al.
Publicado: (2021)

Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated with Rituximab and Mycophenolate Mofetil
por: Green, Sarah, et al.
Publicado: (2016)

Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
por: Al Tabaa, Omar, et al.
Publicado: (2023)

Recalcitrant Hailey-Hailey disease successfully treated with topical ruxolitinib cream and dupilumab
por: Khang, Juna, et al.
Publicado: (2023)

Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic
por: Druce, Katie L, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l6ucp8erhl3kd2u4tvofjq3mhj